HopeStage
Back to all studies
CompletedNCT02008773

Valacyclovir Added to Treatment for Thinking Skills in Early Schizophrenia

About this titleRead the official source — NCT02008773
Medication studyAges 18–40United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 40 years.

Listed locations
Bellflower and 12 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: March 26, 2014
Recruitment status
Completed
Enrollment listed in the registry
170
Sponsor
Indiana University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 40 Years
Official registry ID
NCT02008773
Official title
Show the full official title

A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Bellflower · Los Angeles · Riverside

9 more locations
  • Santa Ana
  • New Haven
  • Lauderhill
  • Indianapolis
  • Wichita
  • Baltimore
  • Rockville
  • Towson
  • Tulsa

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Indiana University, a university.

Did this study involve medication?

Yes. The study involved medication, including Valacyclovir HCI 500 mg tablets and placebo.

Who was this study for?

Listed age limits: 18 years to 40 years.

Want to explore more studies?

Explore studies